Salvatore Thomas Butera - 07 Apr 2022 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: CEO - Volition Veterinary
Signature: /s/ Salvatore Thomas Butera
Issuer symbol: VNRX
Transactions as of: 07 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 08 Apr 2022, 16:03:04 UTC
Previous filing: 18 Nov 2021
Next filing: 17 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VNRX	Stock Option (Right to Buy)	Award	$0	+18,340		$0.000000	18,340	07 Apr 2022	Common Stock	18,340	$3.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 3, 2021, the reporting person was granted an option to purchase 52,400 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 18,340 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 9,170 shares on each of August 3, 2022 and August 3, 2023, respectively.

Content

On August 3, 2021, the reporting person was granted an option to purchase 52,400 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 18,340 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 9,170 shares on each of August 3, 2022 and August 3, 2023, respectively.